美国 · SEC FORM 4
Tenaya Therapeutics, Inc.
TNYA · Nasdaq · CIK 0001858848 · Healthcare · Biotechnology
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
12 同一窗口内观察到的 Form 4 交易行
10 sales · 2 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2025-03-05 · COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC · $25.0M
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出中等
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Ali FarazChief Executive Officer
▼▼○
Tingley WhittemoreChief Medical Officer
▼▼○
Higa TomohiroSVP, Finance
▼
● 买入▼ 卖出○ 其他
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-03-05 · COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC.
近期 Form 4 活动
0买入
33卖出
5其他 Form 4 交易行
19SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出10 sale line(s) · 仅供背景
其他2 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 22,922,426
- 上期报告
- 21,641,185
- 日均成交量
- 3,038,032
- 回补天数
- 7.5
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-03-05 | GOEDDEL DAVID V | 买入 (P) | Common Stock | 35,714,284 | USD 0.70 | USD 24,999,999 | SEC 申报 ↗ |
| 2025-03-05 | COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC | 买入 (P) | Common Stock | 35,714,284 | USD 0.70 | USD 24,999,999 | SEC 申报 ↗ |
| 2024-02-12 | GOEDDEL DAVID V | 买入 (P) | Common Stock | 2,222,222 | USD 4.50 | USD 9,999,999 | SEC 申报 ↗ |
| 2024-02-12 | COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC | 买入 (P) | Common Stock | 2,222,222 | USD 4.50 | USD 9,999,999 | SEC 申报 ↗ |
| 2023-03-10 | GOEDDEL DAVID V | 买入 (P) | Common Stock | 6,779 | USD 2.60 | USD 17,625 | SEC 申报 ↗ |
| 2023-03-10 | COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC | 买入 (P) | Common Stock | 6,779 | USD 2.60 | USD 17,625 | SEC 申报 ↗ |
| 2023-02-08 | GOEDDEL DAVID V | 买入 (P) | Common Stock | 1,500,000 | USD 2.60 | USD 3,900,000 | SEC 申报 ↗ |
| 2023-02-08 | COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC | 买入 (P) | Common Stock | 1,500,000 | USD 2.60 | USD 3,900,000 | SEC 申报 ↗ |
| 2023-01-19 | GOEDDEL DAVID V | 买入 (P) | Common Stock | 69,739 | USD 2.50 | USD 174,348 | SEC 申报 ↗ |
| 2023-01-19 | COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC | 买入 (P) | Common Stock | 69,739 | USD 2.50 | USD 174,348 | SEC 申报 ↗ |
| 2023-01-18 | GOEDDEL DAVID V | 买入 (P) | Common Stock | 135,688 | USD 2.52 | USD 341,934 | SEC 申报 ↗ |
| 2023-01-18 | COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC | 买入 (P) | Common Stock | 135,688 | USD 2.52 | USD 341,934 | SEC 申报 ↗ |
| 2023-01-17 | GOEDDEL DAVID V | 买入 (P) | Common Stock | 49,463 | USD 2.49 | USD 123,163 | SEC 申报 ↗ |
| 2023-01-17 | COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC | 买入 (P) | Common Stock | 49,463 | USD 2.49 | USD 123,163 | SEC 申报 ↗ |
| 2022-11-21 | Srivastava Deepak | 买入 (P) | Common Stock | 230,769 | USD 2.60 | USD 599,999 | SEC 申报 ↗ |
Form 4 申报证据
38 transaction lines in the latest 365-day window; 122 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-10 | Tingley Whittemore | 奖励／授予 (A) | Common Stock | 49,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-10 | Ali Faraz | 奖励／授予 (A) | Common Stock | 122,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-17 | Tingley Whittemore | 卖出 (S) | Common Stock | 5,787 | USD 0.71 | USD 4,109 | SEC 申报 ↗ |
展开近期 Form 4 证据 (22 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-10 | Tingley Whittemore | 奖励／授予 (A) | Common Stock | 49,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-10 | Ali Faraz | 奖励／授予 (A) | Common Stock | 122,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-17 | Tingley Whittemore | 卖出 (S) | Common Stock | 5,787 | USD 0.71 | USD 4,109 | SEC 申报 ↗ |
| 2026-08-17 | Ali Faraz | 卖出 (S) | Common Stock | 22,232 | USD 0.71 | USD 15,785 | SEC 申报 ↗ |
| 2026-05-18 | Tingley Whittemore | 卖出 (S) | Common Stock | 3,121 | USD 0.79 | USD 2,466 | SEC 申报 ↗ |
| 2026-05-18 | Higa Tomohiro | 卖出 (S) | Common Stock | 1,485 | USD 0.79 | USD 1,173 | SEC 申报 ↗ |
| 2026-05-18 | Ali Faraz | 卖出 (S) | Common Stock | 3,390 | USD 0.79 | USD 2,678 | SEC 申报 ↗ |
| 2026-02-25 | COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC | 卖出 (S) | Common Stock | 3,511,826 | USD 0.56 | USD 1,966,623 | SEC 申报 ↗ |
| 2026-02-24 | COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC | 卖出 (S) | Common Stock | 658,440 | USD 0.62 | USD 408,233 | SEC 申报 ↗ |
| 2026-02-23 | COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC | 卖出 (S) | Common Stock | 306,000 | USD 0.60 | USD 183,600 | SEC 申报 ↗ |
| 2026-02-20 | COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC | 卖出 (S) | Common Stock | 523,734 | USD 0.61 | USD 319,478 | SEC 申报 ↗ |
| 2026-02-17 | Tingley Whittemore | 卖出 (S) | Common Stock | 3,518 | USD 0.64 | USD 2,252 | SEC 申报 ↗ |
| 2026-02-17 | Higa Tomohiro | 卖出 (S) | Common Stock | 3,469 | USD 0.64 | USD 2,220 | SEC 申报 ↗ |
| 2026-02-17 | Ali Faraz | 卖出 (S) | Common Stock | 14,862 | USD 0.64 | USD 9,512 | SEC 申报 ↗ |
| 2026-02-11 | COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC | 卖出 (S) | Common Stock | 4,056,573 | USD 0.68 | USD 2,758,470 | SEC 申报 ↗ |
| 2026-02-10 | COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC | 卖出 (S) | Common Stock | 343,717 | USD 0.82 | USD 281,848 | SEC 申报 ↗ |
| 2026-02-03 | Tingley Whittemore | 奖励／授予 (A) | Common Stock | 48,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-03 | Higa Tomohiro | 奖励／授予 (A) | Common Stock | 29,250 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-03 | Ali Faraz | 奖励／授予 (A) | Common Stock | 158,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-17 | Tingley Whittemore | 卖出 (S) | Common Stock | 2,877 | USD 1.33 | USD 3,826 | SEC 申报 ↗ |
| 2025-11-17 | Higa Tomohiro | 卖出 (S) | Common Stock | 1,367 | USD 1.33 | USD 1,818 | SEC 申报 ↗ |
| 2025-11-17 | Ali Faraz | 卖出 (S) | Common Stock | 3,126 | USD 1.33 | USD 4,158 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | TNYA |
| CIK | 0001858848 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 122 transaction lines from 2021-08-03 to 2026-09-10 20 P purchase lines · 73 S sale lines · 29 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.